Cargando…

Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study

Detalles Bibliográficos
Autores principales: Xu, Siyuan, Cheng, Jingning, Wei, Bojun, Zhang, Yang, Li, Yang, Zhang, Zongmin, Liu, Yang, Zhang, Ye, Zhang, Rui, Wang, Kai, Wang, Xiaolei, Liu, Shaoyan, Huang, Ying, Xu, Zhengang, Liu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423182/
https://www.ncbi.nlm.nih.gov/pubmed/32898320
http://dx.doi.org/10.1002/ctm2.142
_version_ 1783570131270500352
author Xu, Siyuan
Cheng, Jingning
Wei, Bojun
Zhang, Yang
Li, Yang
Zhang, Zongmin
Liu, Yang
Zhang, Ye
Zhang, Rui
Wang, Kai
Wang, Xiaolei
Liu, Shaoyan
Huang, Ying
Xu, Zhengang
Liu, Jie
author_facet Xu, Siyuan
Cheng, Jingning
Wei, Bojun
Zhang, Yang
Li, Yang
Zhang, Zongmin
Liu, Yang
Zhang, Ye
Zhang, Rui
Wang, Kai
Wang, Xiaolei
Liu, Shaoyan
Huang, Ying
Xu, Zhengang
Liu, Jie
author_sort Xu, Siyuan
collection PubMed
description
format Online
Article
Text
id pubmed-7423182
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74231822020-08-13 Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study Xu, Siyuan Cheng, Jingning Wei, Bojun Zhang, Yang Li, Yang Zhang, Zongmin Liu, Yang Zhang, Ye Zhang, Rui Wang, Kai Wang, Xiaolei Liu, Shaoyan Huang, Ying Xu, Zhengang Liu, Jie Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-08-12 /pmc/articles/PMC7423182/ /pubmed/32898320 http://dx.doi.org/10.1002/ctm2.142 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Xu, Siyuan
Cheng, Jingning
Wei, Bojun
Zhang, Yang
Li, Yang
Zhang, Zongmin
Liu, Yang
Zhang, Ye
Zhang, Rui
Wang, Kai
Wang, Xiaolei
Liu, Shaoyan
Huang, Ying
Xu, Zhengang
Liu, Jie
Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title_full Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title_fullStr Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title_full_unstemmed Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title_short Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
title_sort development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: a prospective, blinded, multicenter study
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423182/
https://www.ncbi.nlm.nih.gov/pubmed/32898320
http://dx.doi.org/10.1002/ctm2.142
work_keys_str_mv AT xusiyuan developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT chengjingning developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT weibojun developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT zhangyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT liyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT zhangzongmin developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT liuyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT zhangye developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT zhangrui developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT wangkai developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT wangxiaolei developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT liushaoyan developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT huangying developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT xuzhengang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy
AT liujie developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy